Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11760755 Hepatitis B antiviral agents

Patent 11760755 was granted and assigned to Enanta Pharmaceuticals on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Enanta Pharmaceuticals

Current Assignee

Enanta Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Jorden Kass

Jiajun Zhang

Xiaowen Peng

Byung-Chul Suh

Yao-Ling Qiu

Xuri Gao

Hui Cao

Wei Li

...

Date of Patent

September 19, 2023

Patent Application Number

16892373

Date Filed

June 4, 2020

Patent Citations

US Patent 7615569 Inhibitors of ion channels

US Patent 7232825 Phenylaminopyrimidine derivatives and methods of use

US Patent 7312214 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors

US Patent 7411003 Inhibition of Hepatitis B virus by cyclohexenone compounds from

US Patent 8420823 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient

US Patent 9447086 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection

US Patent 9498479 Dihydropyrimidine compounds and their application in pharmaceuticals

US Patent 9573941 Processes for preparing dihydropyrimidine derivatives and intermediates thereof

...

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11760755 Hepatitis B antiviral agents

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool